logo

Investment Plans

To start earning, you should pick an investment plan. We have plans for all pocket sizes

Silver

Basic
5% / 30 days
  • USD500.00 - USD1,000.00
  • Monthly
  • 5% +Capital

Silver Plus

Basic
15% / 3 months
  • USD1,000.00 - USD2,000.00
  • Monthly
  • 15% +Capital

Gold

Popular
10% / 30 days
  • USD2,000.00 - USD5,000.00
  • Monthly
  • 10% +Capital

Gold Plus

Popular
20% / 3 months
  • USD5,000.00 - USD10,000.00
  • Monthly
  • 20% +Capital

Platinum

Popular
30% / 30 days
  • USD10,000.00 - USD30,000.00
  • Monthly
  • 30% +Capital

Platinum Plus

VIP
90% / 3 months
  • USD30,000.00 - USD50,000.00
  • Monthly
  • 90% +Capital

Diamond

Premium
180% / 6 months
  • USD70,000.00 - USD100,000.00
  • Monthly
  • 180% +Capital

Diamond Plus

Premium
300% / 3 years
  • USD100,000.00 - USD200,000.00
  • Yearly
  • 300% +Capital

Royal Diamond

Royal
600% / 6 years
  • USD500,000.00 - USD1,000,000.00
  • Yearly
  • 600% +Capital

Black Diamond

Ultimate
2000% / 10 years
  • USD10,000,000.00 - USD100,000,000.00
  • Yearly
  • 2000% +Capital

Loan Plans

We have loans to assist you get started in your investing journey

Silver

2.5% / 3 months
  • USD5,000.00 - USD10,000.00
  • DTQ: USD5,000.00
  • 2.5% +Principal

500$ Promotion Bonus

0% / 10 years
  • USD500.00 - USD500.00
  • DTQ: USD250.00
  • 0% +Principal
about us

About Us

Crypto Future Algorithm is an established international financial brokerage company. We specialize in profitable cryptocurrency trading, mining, investment and foresting trading. We have a team of competent traders.
We are determined to providing conducive investment to our esteemed investors, minimizing losses, and offering safe investments. With our edge cutting technology, we are able to automate trading, investments and returns. With Crypto Future Algorithm, there is guaranteed return on investment.

Learn More

How To Invest With Crypto Future Algorithm

Investing with Crypto Future Algorithm is very easy. Follow the steps below to start investing

Register

Sign up for an account by going to the signup page and fill in your details

Fund Wallet

Fund your trading wallet by depositing money to your account

Invest

Choose from our various investment plans and start earning

Withdraw

Withdraw money through your preferred method

Profit Calculator

Find out how much you will be making from your investment using our profit calculator below

Our Team

Our team is made of expert traders, with several years of experience in trading and financial management

team member photo

Barton E. Kelley

Blockchain Developer
team member photo

Noel C. Egger

Cryptocurrency Trader
team member photo

Rex R. Murillo

Cryptocurrency Analyst
team member photo

Jerald T. Beauchamp

Cryptocurrency Engineer
team member photo

Cheryl T. Carter

Cryptocurrency Compliance Officer
team member photo

Gail J. Ennis

Cryptocurrency Marketing Manager
team member photo

Laura T. Lee

Cryptocurrency Product Manager
team member photo

Jay V. Venters

Cryptocurrency UX/UI Designer
team member photo

Marylee E. Edmonds

Cryptocurrency Researcher
team member photo

Robert C. South

Cryptocurrency Legal Counsel
team member photo

Robert D. Arledge

Cryptocurrency Security Specialist
team member photo

Winifred J. Weigel

Cryptocurrency Operations Manager

Frequently Asked Questions

Below are frequently asked questions from our users

Our stats speaks volume

We are proud to serve you since inception

Users

1.2K

Deposits

687.3K

Withdrawals

47.8M

Latest Deposits and Withdrawals

Below are recent deposits and withdrawals from members

Deposits
Withdrawals
User
Date
Amount
Status
Shawn
USD250.00
9 weeks ago
Approved
Shawn
USD250.00
24 weeks ago
Approved
Patrick
USD364.52
1 month ago
Approved
Shawn
USD250.00
1 month ago
Approved
Shawn
USD250.00
1 month ago
Approved
Shawn
USD500.00
1 month ago
Approved
Shawn
USD1,000.00
1 month ago
Approved
Shawn
USD495.00
1 month ago
Approved
Patrick
USD360.00
1 month ago
Approved
Patrick
USD1,445.00
1 month ago
Approved

Testimonials

Bellow is what our esteamed investors are saying

Payment Methods

We accept the following deposit methods

Latest Financial Updates

Read latest financial news update from our blog

Retail investors turn cautious as IPO market shows signs of recovery
Retail investors turn cautious as IPO market shows signs of recovery

Notwithstanding the early signs of revival in the primary markets, retail investors have t...

Admin | Finance | 17 mins ago

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer |
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer |

Xilio Therapeutics (XLO, Financial) announces a 26% objective response rate for vilastobar...

Admin | Finance | 17 mins ago

BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025 | ONC Stock News
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025 | ONC Stock News

BRUKINSA (zanubrutinib) shows strong efficacy in treating frontline Chronic Lymphocytic Le...

Admin | Finance | 37 mins ago

ENHERTU® Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel as a Second-Line Therapy in Patients with HER2 Positive Unresectable or Metastatic Gastric Cancer in DESTINY-Gastric04 Phas
ENHERTU® Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel as a Second-Line Therapy in Patients with HER2 Positive Unresectable or Metastatic Gastric Cancer in DESTINY-Gastric04 Phas

ENHERTU® (trastuzumab deruxtecan) showed a 30% reduction in risk of death versus ramucirum...

Admin | Finance | 37 mins ago

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer | ARVN Stock News
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer | ARVN Stock News

Vepdegestrant shows a significant 2.9-month improvement in median progression-free surviva...

Admin | Finance | 37 mins ago

Moderna (MRNA) Gains FDA Approval for New COVID-19 Vaccine
Moderna (MRNA) Gains FDA Approval for New COVID-19 Vaccine

Moderna secures FDA approval for the innovative mNEXSPIKE COVID-19 vaccine. Analysts pred...

Admin | Finance | 57 mins ago

Edible Oil Bodies Extend Support To 10% Custom Duty Cut On Crude Oil
Edible Oil Bodies Extend Support To 10% Custom Duty Cut On Crude Oil

Welcoming the decision, SEA President Sanjeev Asthana said, "The government's decision to...

Admin | Finance | 57 mins ago

UN Glaciers Conference: India Contends That Pakistan Violated Indus Waters Treaty Via Terrorism
UN Glaciers Conference: India Contends That Pakistan Violated Indus Waters Treaty Via Terrorism

"However, the unrelenting cross border terrorism from Pakistan interferes with an ability...

Admin | Finance | 57 mins ago

View More

Join Our Newsletter

join our newsletter to receive update from us

Get In Touch

Fill the form below to make inquirires. You can also contact us via livechat, email, support ticket or using the contact details below.

0

800 State Rte 2004 Philadelphia, Pennsylvania